Early results indicate that increased production of intracellular nuclear-factor 6B and cyclo-oxygenase-2 (COX-2) may be key phenomena in CFS indicating activation of immune-inflammatory pathways in that illness (Maes et al. 2006). Here, PTGS2 is linked to myalgic encephalomeyelitis/chronic fatigue syndrome.